Explores assessment differences using motion sickness rating scales, suggesting implications for symptom evaluation.
The assessment of motion sickness typically relies on self-reports. It is unclear whether rating general sickness (e.g., Fast Motion Sickness scale; FMS) or specific symptoms (e.g., Motion Illness Symptoms Classification; MISC) impacts the assessment. Different from prior studies, we investigated how FMS and MISC ratings developed during the same motion exposure. Both scales showed comparable time courses with a similar direction of rating transitions. To investigate the development of nausea versus non-nausea symptoms, participants also rated the MISC2D - a two-dimensional MISC-derivative separating these symptoms - alternatingly with the FMS in another exposure. We found no clear reduction in general sickness or non-nausea symptoms at nausea onset. Nausea-related symptoms, starting with stomach awareness, preceded non-nausea symptoms in over half our sample. Although we did not intend the MISC2D as a new scale, it proved suitable for repeated administration while capturing distinct motion sickness aspects.
No takes yet. Share an insight, caveat, or question.
Reuten et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: